KALLIKREIN-KININ SYSTEM, PROTEASE INHIBITORS FOR CHRONIC GLOMERULONEPHRITIS

dc.contributor.authorTursunbaev A.K.
dc.contributor.authorKarimova N.A..
dc.date.accessioned2025-12-29T17:59:20Z
dc.date.issued2025-06-11
dc.description.abstractObjective: to determine the state of the kallikrein-kinin system and protease inhibitors in various clinical forms of glomerulonephritis in children. Materials and methods of the study. To solve the set tasks, 85 children with glomerulonephritis aged 3 to 15 years will be examined. Results and discussion. Patients of the first group showed significant activation of the KKS. The activity of K exceeded the norm by 1.7 times (p<0.001). The level of PC was reduced by 1.1 times (p<0.01). Conclusions: the state of the KKS has certain features in various clinical forms of CGN: mild CGN is characterized by pronounced activation of the KKS controlled by the protease system, probably caused by immune inflammation.
dc.formatapplication/pdf
dc.identifier.urihttps://webofjournals.com/index.php/5/article/view/4560
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/24770
dc.language.isoeng
dc.publisherWeb of Journals Publishing
dc.relationhttps://webofjournals.com/index.php/5/article/view/4560/4514
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWeb of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 3 No. 6 (2025): WOM; 119-123
dc.source2938-3765
dc.subjectKallikrein-kinin system, glomerulonephritis, children.
dc.titleKALLIKREIN-KININ SYSTEM, PROTEASE INHIBITORS FOR CHRONIC GLOMERULONEPHRITIS
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
ak_2025_kallikrein-kinin_system_protease_inhibit.pdf
item.page.filesection.size
588.7 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections